Cargando…
The Time Has Come for Quantitative Protein Mass Spectrometry Tests That Target Unmet Clinical Needs
[Image: see text] Protein mass spectrometry (MS) is an enabling technology that is ideally suited for precision diagnostics. In contrast to immunoassays with indirect readouts, MS quantifications are multiplexed and include identification of proteoforms in a direct manner. Although widely used for r...
Autores principales: | Smit, Nico P. M., Ruhaak, L. Renee, Romijn, Fred P. H. T. M., Pieterse, Mervin M., van der Burgt, Yuri E. M., Cobbaert, Christa M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American
Chemical Society
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7944566/ https://www.ncbi.nlm.nih.gov/pubmed/33522792 http://dx.doi.org/10.1021/jasms.0c00379 |
Ejemplares similares
-
Development and
Provisional Validation of a Multiplex
LC-MRM-MS Test for Timely Kidney Injury Detection in Urine
por: van Duijl, Tirsa T., et al.
Publicado: (2021) -
HILIC–MRM–MS
for Linkage-Specific Separation
of Sialylated Glycopeptides to Quantify Prostate-Specific Antigen
Proteoforms
por: van der Burgt, Yuri E. M., et al.
Publicado: (2020) -
Antithrombin diagnostics by mass spectrometry: Development and analytical validation of a next-generation test
por: Kruijt, Mirjam, et al.
Publicado: (2023) -
Unraveling a borderline antithrombin deficiency case with quantitative mass spectrometry
por: Kruijt, Mirjam, et al.
Publicado: (2021) -
Rational selection of a biomarker panel targeting unmet clinical needs in kidney injury
por: van Duijl, T. T., et al.
Publicado: (2021)